Log in | Register

Potential role of IgM-enriched immunoglobulin as adjuvant treatment for invasive meningococcal disease

Carlo Tascini| Fiorentino Fraganza| Francesca Salani| Emanuela Sozio| Marco Rossi| Francesco Sbrana| Novella Carannante| Maria Daniela Chiesa| Andrea Ripoli| Giacomo Bertolino| Massimo Di Pietro| Alessandro Bartoloni| Francesco Menichetti
Volume 44, Issue 2 / February , 2018

Pages 261 - 262

No abstract available.


  1. Greenfield S, Sheehe PR, Feldman HA (1971) Meningococcal carriage in a population of “(normal)” families. J Infect Dis 123:67–73
    • View reference on publisher's website
    • View reference on PubMed
  2. Janda WM, Knapp JS (2003) Neisseria and Moraxella catarrhalis. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology, 8th edn. ASM Press, Washington, DC, pp 585–608
  3. Flexner S (1913) The results of the serum treatment in thirteen hundred cases of epidemic meningitis. J Exp Med 17:553–576
    • View reference on publisher's website
    • View reference on PubMed
  4. Busani S, Damiani E, Cavazzuti I, Donati A, Girardis M (2016) Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness. Minerva Anestesiol 82:559–572
    • View reference on PubMed
  5. Garbett ND, Munro CS, Cole PJ (1989) Opsonic activity of a new intravenous immunoglobulin preparation: pentaglobin compared with sandoglobulin. Clin Exp Immunol 76:8–12
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement